https://www.selleckchem.com/pr....oducts/lenalidomide-
To investigate the molecular characteristics of AGEJ compared with EAC and gastric adenocarcinoma. Classification of AGEJ based on differential molecular characteristics between EAC and gastric adenocarcinoma has been long-standing controversy but rarely conducted due to anatomical ambiguity and epidemiologic difference. The molecular classification model with Bayesian compound covariate predictor was developed based on differential mRNA expression of EAC (N = 78) and GCFB (N = 102) from the Cancer Genome Atlas (TCGA) cohort.
Like
Comment
Share
